CDC: Increase in Tianeptine Exposures From 2014 to 2017

Share this content:
CDC: Increase in Tianeptine Exposures From 2014 to 2017
CDC: Increase in Tianeptine Exposures From 2014 to 2017

FRIDAY, Aug. 17, 2018 (HealthDay News) -- From 2014 to 2017 there was an increase in tianeptine exposure calls reported by poison control centers to the National Poison Data System, and they mainly occurred among those aged 21 to 40 years, according to research published in the Aug. 3 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Tharwat El Zahran, M.D., from the CDC in Atlanta, and colleagues characterized exposure to tianeptine, an atypical tricyclic drug not approved for medical use in the United States, by analyzing all tianeptine-related exposure calls reported by poison control centers to the National Poison Data System during 2000 to 2017.

The researchers found that during 2014 to 2017 there was an increase in tianeptine exposure calls, including those for intentional abuse or misuse, indicative of a possible emerging public health risk. Most of the exposures occurred among those aged 21 to 40 years and had moderate outcomes. The most commonly reported health effects were neurologic, cardiovascular, and gastrointestinal signs and symptoms; some effects mimicked opioid toxicity. Clinical effects of withdrawal were also reported in a substantial number of tianeptine exposure calls. There were 83 tianeptine exposures with noted co-exposures, most commonly phenibut, ethanol, benzodiazepines, and opioids.

"The associated outcomes and health effects associated with tianeptine use suggest a possible emerging public health risk and underscore the need for public outreach to increase awareness," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »